Ganitumab (IGF1R/CD221) - Onderzoeksgraad Biosimilar
Gecertificeerd

Ganitumab (IGF1R/CD221) - Onderzoeksgraad Biosimilar

Catalog #: 10-189
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Ganitumab has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, Breast Cancer, Breast Tumors, and Breast Neoplasms, among others.

Immunogen

Homo sapiens / IGF1R/CD221 [Homo sapiens]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Cancer

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG1-kappa

NCBI Organism

Homo sapiens

Other Product Names

AMG 479

Beschrijving

Ganitumab (IGF1R/CD221) - Onderzoeksgraad Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamGanitumab (IGF1R/CD221) - Onderzoeksgraad Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer10-189